When human immunodeficiency virus type 1 (HIV-1) was identified as the causative agent of AIDS, and the first clinical trials for HIV anti-viral therapies were conducted, CD4 T-cell counts were part of the enrollment criteria for the trials. The gene discussed is CD4; the disease is AIDS.